Liliana Alfaya Virzi
About Liliana Alfaya Virzi
Liliana Alfaya Virzi is an Executive Medical Director at Tesaro/GSK and an Immuno-oncology Medical Affairs Lead at Bristol-Myers Squibb, with extensive experience in immuno-oncology, cross-tumor safety, product design, and delivery.
Current Roles in Immuno-oncology
Liliana Alfaya Virzi currently holds significant leadership positions at Bristol-Myers Squibb in New Jersey, United States. She serves as the Immuno-oncology Medical Affairs Lead, focusing on cross-tumor safety, product design and delivery, and pediatrics. Additionally, she is the Worldwide Medical Director for the immuno-oncology agents Nivolumab and Ipilimumab. These roles highlight her extensive expertise and responsibility in the development and oversight of innovative cancer therapies.
Position at Tesaro/GSK
Since April 2019, Liliana Alfaya Virzi has been contributing to Tesaro, a subsidiary of GSK, as the Executive Medical Director. In this role, she oversees medical affairs and plays a critical role in driving the company's oncology pipeline forward. Her primary focus includes enhancing cross-tumor safety, improving product design, and optimizing delivery systems for oncology therapeutics.
Experience at Novartis
From 2009 to 2014, Liliana Alfaya Virzi worked at Novartis in Basel, Switzerland, as the Director of Scientific Communications. Over the span of five years, she managed scientific communications, ensuring the accurate and effective dissemination of research findings and corporate news. This role added to her substantial experience in bridging the gap between scientific research and its practical, communicative applications.
Earlier Career in Medical Directorship
Liliana Alfaya Virzi's earlier career included positions as Medical Director at several notable institutions. She held a Medical Director role at Health Science Communications in New York from 2006 to 2008 and at Jhasim-johns Hopkins Advanced Studies in Medicine from 2004 to 2006. These roles involved managing medical content, overseeing clinical research projects, and ensuring compliance with medical standards and regulations.
Educational Background and Research
Liliana Alfaya Virzi completed her Doctor of Philosophy in Immunology at the Universidad De Santiago De Compostela. She has a strong academic and research background, including roles as a Research Scientist at Icahn School of Medicine At Mount Sinai from 2000 to 2002, and at Omrf/Mount Sinai Medical Center from 1999 to 2003. She also gained international experience as a Visitor International Student and Research Technician at The Advanced Center For Genome Technology from 1997 to 1999.